Via, M. A., Chandra, H., Araki, T., & al, e. (2010). Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes. Dove Medical Press.
Style de citation Chicago (17e éd.)Via, Michael A., Himani Chandra, Takako Araki, et et al. Bromocriptine Approved as the First Medication to Target Dopamine Activity to Improve Glycemic Control in Patients with Type 2 Diabetes. Dove Medical Press, 2010.
Style de citation MLA (8e éd.)Via, Michael A., et al. Bromocriptine Approved as the First Medication to Target Dopamine Activity to Improve Glycemic Control in Patients with Type 2 Diabetes. Dove Medical Press, 2010.
Attention : ces citations peuvent ne pas être correctes à 100%.